01 / 12
Enquirer Consulting Group / Prepared for CCL Pharmaceuticals
August 2026

Two hundred products.
The next market is a person.

Prepared for Syed Umair Maroof, to go with Monday's note. It reads how companies in this industry open new markets, not how CCL runs its own.
DesignBuildRunHand over
BUILDRUNOWN
Enquirer AI is the outbound engine of Enquirer Consulting Group
What we see

Expansion is a people problem.

01
A portfolio of more than two hundred products across the major therapeutic categories carries more to sell than any one business development team can take into every market.
02
In this industry the next distributor, importer or licensing partner is almost never the one who calls first.
03
Trade fairs put a few hundred of them in one hall for three days a year. For the rest of the year that channel is quiet.
04
The buyer is a named person: a country manager, a head of in licensing, a portfolio director, a tender lead.
05
Those seats are listable, market by market. Most companies never build the list.
Prepared for CCL Pharmaceuticals
Where this goes

From trade fairs to a named list.

Today
.
In this industry, partner search usually runs through trade events, existing agents and inbound approaches.
.
That reaches partners who are already looking. It is silent about the ones who are not.
.
Coverage tends to follow whoever holds the relationship, rather than a plan for the map.
In the first weeks and months
+
A named list of distributors, importers, licensing teams and institutional buyers, by country and by therapeutic focus.
+
A message per person that names the therapy area and the market, rather than sending a company brochure.
+
Positive replies handed to your commercial team with the context behind them.
+
One view of which markets have been worked properly and which have not.
Enquirer Consulting Group
How the engagement works

Build. Run. Own.

01 / BUILD

Build

We design, staff and stand up the complete unit. The named-account data, the messaging, the outbound engine, the automation and the reporting.

02 / RUN

Run

We run it in market for a fixed four months and prove it on real booked meetings, not slides. First conversations land early.

03 / OWN

Own

We hand over the playbook, the tooling, the dashboards and a trained operator. You own the engine.

One contractor, a network of specialists. One point of contact, and you never manage a stack of tools or freelancers.
We build it, run it in market, then hand you the keys
What we build for CCL Pharmaceuticals

A partner channel you own.

The market map

Country by country, the distributors, importers, licensing teams and institutional buyers who move product in your therapy areas, with the named person who owns the decision inside each.

Message per partner

Written for one country manager or portfolio lead, around the therapy area and the market they run. No mass mail, no product claims.

Handover

The list, the messaging, the tooling and a trained operator stay with your team at the end of the build.

The output is not a spreadsheet of leads. It is a partner development channel your own people can run.
Enquirer Consulting Group
The engine, in plain terms

Every message, written for one real person.

01

Target

We build the list of distributors, importers, licensing teams and institutional buyers market by market, then find the person inside each who owns your therapy area.

02

Personalize

AI reads each profile and writes a unique message. No templates.

03

Hand off warm

A positive reply pings you and your operator with the prospect and a way to reach them.

04

You take it from there

You take pre-qualified conversations. The engine handles everything before it.

Research-led and human-reviewed. Every message is on-brand, and most of the volume runs on capacity we operate, not only your account.
Enquirer AI is the outbound engine of Enquirer Consulting Group
Why this fits a pharmaceutical exporter

The registrations are done. The introductions are not.

01

Regulated, so the copy stays clean

Outreach opens a conversation between two companies. No product claims, no clinical language, nothing a regulator would take issue with.

02

Market by market

Every country is a separate list with separate buyers, which suits an engine that works one named person at a time.

03

Built, then handed over

When the build ends the channel sits with your commercial team, not with an outside agency you keep paying to hold it.

Enquirer Consulting Group
Proof, in the field

Numbers from live campaigns, not projections.

Tim Rath
Chief Operating Officer, Innovative Radiology
Enquirer AI helps us identify the right people and start the conversation in a much smarter way.
$10M+
New business sold for clients.
3,500+
Qualified conversations generated.
100,000+
Decision makers reached for clients.
Fixed engagement, then you own it.
Why ECG

You own it at the end. That is the difference.

+
Without building an outbound team from scratch.
+
Without a permanent agency on retainer forever.
+
Without a stack of tools and freelancers to manage.
+
Without lock-in. You own the engine, including the operator who runs it.
A freelancer sends emails. An agency rents you reps. A consultancy hands you a slide deck. We design the engine, staff it, run it, prove it on real meetings, then hand you the keys.
Enquirer Consulting Group
How we start

Stand up fast. Prove it. Then scale.

Stand up

Build

The named-account data, the messaging, the engine and the dashboard. Day-one capacity from warmed assets and managed seats.

Prove

The test

Run against the KPIs we agree up front. First meetings on the calendar early.

Scale

Ramp

Once the numbers hold, ramp the seats and breadth to the volume you want.

Own

Hand over

Playbook, tooling, dashboards and a trained operator. The engine is yours.

Onboarding sets the targeting and the voice first, so the outreach lands warmer every week.
Enquirer Consulting Group
Next step

Let's see if the mechanism fits.

  1. A short call with Paul, 20 minutes, at a time that works for you.
  2. Paul brings the named accounts and the exact people we would start with. You tell us if the list is right.
  3. If it fits, we agree the scope and a start date. If not, you keep the read.
Reply with two or three times that suit and we will work around you, or grab a slot at calendly.com/enquirer/review.
Enquirer AI is the outbound engine of Enquirer Consulting Group
Enquirer Consulting Group

We build it, run it in market, then hand you the keys.

Paul Smaldone   /   paul@enquirerconsulting.com   /   calendly.com/enquirer/review
Enquirer AI is the outbound engine of Enquirer Consulting Group. Prepared for CCL Pharmaceuticals.